Hongtao Liu is a Hematology physician affiliated with University of Wisconsin Carbone Cancer Center. OpenAlex indexes 276 publications with 5,638 citations (h-index 36); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 537921443
Telephone
608-265-1700Provider last certified this registry record 27 Jun 2023.
Clinical trials
- Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
Sponsor: University of Wisconsin, Madison
- Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients
Sponsor: West China Hospital
- Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
Sponsor: University of Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments
- Stemline Therapeutics Inc.Program year20251 payment
- Incyte CorporationProgram year20249 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
27.6%Fluoroquinolone Antibacterial14%Levofloxacin100%Part D≥12 patientsAzole Antifungal13.6%Fluconazole100%Part D<11 patientsMetabolism & gastrointestinal
27.6%Serotonin-3 Receptor Antagonist10.5%Ondansetron Hcl100%Part D≥12 patientsBile Acid10.1%Ursodiol100%Part D<11 patients+ 1 more class in this area
Dermatology
26.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor26.8%Acyclovir100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database
International Journal of Surgery
2024 - Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead
Journal of Hematology & Oncology
2024 - Combination strategies to maximize the benefits of cancer immunotherapy
Journal of Hematology & Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Natalie Callander, MD
University of Wisconsin Carbone Cancer Center
Glenn Liu, MD
University of Wisconsin Carbone Cancer Center
Susan Payne, MD
University of Wisconsin Carbone Cancer Center
Vaishalee Kenkre, MD
University of Wisconsin Carbone Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”